Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021

by Dario Trapani, Giuseppe Curigliano
Published 2022-03-01

Antibody–drug conjugates in solid tumors: a look into novel targets

by Carmen Criscitiello, Stefania Morganti, Giuseppe Curigliano
Published 2021-01-01

Targeting HER2 in breast cancer: new drugs and paradigms on the horizon

by Paolo Tarantino, Stefania Morganti, Giuseppe Curigliano
Published 2021-04-01

Recent advances in triple negative breast cancer: the immunotherapy era

by Antonio Marra, Giulia Viale, Giuseppe Curigliano
Published 2019-05-01

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets

by Philip Lammers, Carmen Criscitiello, Giuseppe Curigliano, Ira Jacobs
Published 2014-09-01

The HER2-low revolution in breast oncology: steps forward and emerging challenges

by Eleonora Nicolò, Luca Boscolo Bielo, Giuseppe Curigliano, Paolo Tarantino
Published 2023-02-01

Management of Cardiac Toxicity Induced by Chemotherapy

by Dario Trapani, Paola Zagami, Eleonora Nicolò, Gabriella Pravettoni, Giuseppe Curigliano
Published 2020-09-01

Antibody–Drug Conjugates for the Treatment of Breast Cancer

by Chiara Corti, Federica Giugliano, Eleonora Nicolò, Liliana Ascione, Giuseppe Curigliano
Published 2021-06-01

Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges

by Lorenzo Guidi, Gloria Pellizzari, Paolo Tarantino, Carmine Valenza, Giuseppe Curigliano
Published 2023-02-01

Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?

by Andrea Aran, Laia Garrigós, Giuseppe Curigliano, Javier Cortés, Mercè Martí
Published 2022-03-01

Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”

by Lucia Gelao, Carmen Criscitiello, Angela Esposito, Aron Goldhirsch, Giuseppe Curigliano
Published 2014-03-01

Immuno-oncology trends: preclinical models, biomarkers, and clinical development

by Giuseppe Curigliano, Maryland Rosenfeld Franklin, Suso Platero, Kamal S Saini, Steven Anderson
Published 2022-01-01

Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference

by Michael Gnant, Giuseppe Curigliano, Hansjörg Senn, Beat Thürlimann, Walter P. Weber
Published 2022-03-01

Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies

by Gabriele Antonarelli, Federica Giugliano, Chiara Corti, Matteo Repetto, Paolo Tarantino, Giuseppe Curigliano
Published 2021-08-01

PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative

by Liliana Ascione, Paola Zagami, Eleonora Nicolò, Edoardo Crimini, Giuseppe Curigliano, Carmen Criscitiello
Published 2022-10-01

Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment

by Carmine Valenza, Beatrice Taurelli Salimbeni, Celeste Santoro, Dario Trapani, Gabriele Antonarelli, Giuseppe Curigliano
Published 2023-01-01

Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies

by Carmen Belli, Gabriele Antonarelli, Matteo Repetto, Luca Boscolo Bielo, Edoardo Crimini, Giuseppe Curigliano
Published 2022-09-01

Use of Antibody–Drug Conjugates in the Early Setting of Breast Cancer

by Chrysanthi Koukoutzeli, Dario Trapani, Liliana Ascione, Elias Kotteas, Antonio Marra, Carmen Criscitiello, Giuseppe Curigliano
Published 2024-06-01

Future potential targets of antibody-drug conjugates in breast cancer

by Chiara Corti, Luca Boscolo Bielo, Ambra Carnevale Schianca, Beatrice Taurelli Salimbeni, Carmen Criscitiello, Giuseppe Curigliano
Published 2023-06-01

Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2– breast cancer

by Giuseppe Curigliano, Rebecca Dent, Antonio Llombart-Cussac, Mark Pegram, Lajos Pusztai, Nicholas Turner, Giuseppe Viale
Published 2023-06-01